We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Karuna Therapeutics Inc
2 own
5 watching
Current Price
$0
$0.58
(0.25%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
8,744.4M
52-Week High
278.2532
52-Week Low
93.47
Average Volume
0.01M
Dividend Yield
--
P/E Ratio
--
Market Capitalization8,744.4M52-Week High278.253252-Week Low93.47Average Volume0.01MDividend Yield--P/E Ratio--What does the Karuna Therapeutics Inc do?
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.
Read More
How much money does Karuna Therapeutics Inc make?
News & Events about Karuna Therapeutics Inc.
Business Wire
1month ago
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter ended March 31, 2023. The following information represents select highlights from the full UK annual report...
Business Wire
2 months ago
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the pricing of an underwritten public offering of 2,479,391 shares of its common...
Zolmax
3 months ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) insider Stephen K. Brannan sold 5,000 shares of the companys stock in a transaction that occurred on Thursday, February 9th. The shares were sold at an average price of $192.37, for a total transaction of $961,850.00. Following the transaction, the ...
Ticker Report
4 months ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) Director James Healy sold 6,027 shares of Karuna Therapeutics stock in a transaction that occurred on Friday, January 13th. The shares were sold at an average price of $199.90, for a total value of $1,204,797.30. Following the completion of ...
Zolmax
4 months ago
Karuna Therapeutics, Inc. (NASDAQ:KRTX Get Rating) insider Stephen K. Brannan sold 5,000 shares of the stock in a transaction on Monday, January 9th. The stock was sold at an average price of $197.52, for a total transaction of $987,600.00. Following the completion of the sale, the insider now owns ...
Frequently Asked Questions
Frequently Asked Questions
What is Karuna Therapeutics Inc share price today?
Can Indians buy Karuna Therapeutics Inc shares?
How can I buy Karuna Therapeutics Inc shares from India?
Can Fractional shares of Karuna Therapeutics Inc be purchased?
What are the documents required to start investing in Karuna Therapeutics Inc stocks?
What is today’s traded volume of Karuna Therapeutics Inc?
What is today’s market capitalisation of Karuna Therapeutics Inc?
What is the 52-Week High and Low Range of Karuna Therapeutics Inc?
What percentage is Karuna Therapeutics Inc down from its 52-Week High?
What percentage is Karuna Therapeutics Inc up from its 52-Week Low?
Current Price
$0
$0.58
(0.25%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.